Korean Journal of Family Medicine (가정의학회지)

The Korean Academy of Family Medicine (대한가정의학회)
권호 표지
DOI QR코드

DOI QR Code

Recent Update in Adult Immunization

성인예방접종의 최신 권고안

  • Yoo, Sun-Mi (Department of Family Medicine, Inje University Haeundae Paik Hospital)
  • 유선미 (인제대학교 해운대백병원 가정의학과)
  • Received : 2010.03.30
  • Accepted : 2010.04.19
  • Published : 2010.05.20
⟨ Previous Next ⟩

Abstract

Immunization is the most effective and cost-beneficial means to prevent infectious diseases in adults as well as in children. However, adult immunization has been beyond the center of attention relatively to children's immunization in Korea. Since the Korean Academy of Family Medicine had published "Vaccination for Adults" in 1994, a recent update was done in this field by the Korean Centers for Disease Control and Prevention and the Korean Society of Infectious Diseases. This paper reviews standard immunization for healthy persons and supplementary immunization for persons with underlying diseases based on those recent recommendations. General information, indications, dosage, route of administration, efficacy and safety were reviewed for vaccination of influenza, pneumococcal infection, tetanus, hepatitis A, hepatitis B, human papilloma virus, varicella and measles/mumps/rubella.

예방접종은 소아 및 성인에서 전염병을 예방하는데 가장 효과적이고 비용-편익적인 수단이다. 그러나 국내에서 성인 예방접종은 소아에 대한 접종에 비해 상대적으로 주목을 받지 못하였다. 1994년 대한가정의학회에서 "성인예방접종"이 발간된 후 최근 질병관리본부-대한의사협회(2006) 및 대한감염 학회(2007)에서 최근 경향과 국내의 감염질환 실태, 예방접종 현황을 감안하여 성인예방접종 권고안을 발표하였다. 이 글에서는 국내외 최신 예방접종 권고안을 중심으로 우리나라 성인에게 필요한 예방접종의 일반적인 특성, 접종대상, 용량 및 접종방법, 효능 및 안정성을 기술하였다. 구체적으로 인플루엔자, 폐렴사슬알균 감염, 파상풍 디프테리아, A형간염, B형간염, 사람유두종바이러스, 수두, 홍역 유행성이하선염 풍진에 대한 내용이 다루어졌다.

Keywords

References

  1. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993;328:1252-8. https://doi.org/10.1056/NEJM199304293281708
  2. The Korean Academy of Family Medicine. Vaccination for adults. Seoul: Gimm-Young Publishers, Inc; 1994.
  3. The Korean Society of Infectious Diseases. Vaccination for adult. Seoul: Koonja Publishing, Inc; 2007.
  4. Chung MH. Adult immunization. Korean J Med 2008;74:344-7.
  5. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med 2010;152:36-9. https://doi.org/10.7326/0003-4819-152-1-201001050-00008
  6. Centers for Disease Control and Prevention. ACIP Provisional Recommendations for the Use of Influenza Vaccines [Internet]. Atlanta: Centers for Disease Control and Prevention; 2010 [cited 2010 Mar 18]. Available from: http://www.cdc.gov/vaccines/recs/provisional/downloads/flu-vac-mar-2010-508.pdf.
  7. Kang JH, Kim HB, Sohn JW, Lee SO, Chung MH, Cheong HJ, et al. Adult immunization schedule recommended by the Korean Society of Infectious Diseases, 2007. Infect Chemother 2008;40:1-13. https://doi.org/10.3947/ic.2008.40.1.1
  8. Korea Centers for Disease Control and Prevention. The main changes of revised "Influenza A(H1N1) 2009 control and prevention guideline" in Korea. Public Health Wkly Rep 2010;3:101-4.
  9. Korea Centers for Disease Control and Prevention. Influenza A(H1N1) 2009 vaccination program in Korea. Public Health Wkly Rep 2009;2:761.
  10. Roh HO, Sohn YM, Park MS, Choi BY, Bang KN, Ki MR, et al. A seroepidemiologic study of hepatitis A virus in the healthy children and adolescent in Kyonggi-do province. Korean J Pediatr Infect Dis 1997;4:232-9.
  11. Lee JM, Park HK, Choi KY, Kim HK, Jung JO, Suh SO, et al. Incidence and seroprevalence of hepatitis A virus among Korean auxiliary police officers. Infect Chemother 2007;39:292-5.
  12. Song YB, Lee JH, Choi MS, Koh KC, Paik SW, Yoo BC, et al. The age-specific seroprevalence of hepatitis A virus antibody in Korea. Korean J Hepatol 2007;13:27-33.
  13. Korea Centers for Disease Control and Prevention. Risk factors, mathematical modeling and economic analysis for hepatitis A in Korea. Public Health Wkly Rep 2010;3:85-90.
  14. Kim S, Kwak JI, Song YM. Cervical cancer and human papillomavirus vaccines. J Korean Acad Fam Med 2008;29:821-30.
  15. Munoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009;373:1949-57. https://doi.org/10.1016/S0140-6736(09)60691-7
  16. Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, et al. Comparison of the immunogenicity and safety of $Cervarix^{TM}$ and $Gardasil{\circledR}$ human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin 2009;5:705-19. https://doi.org/10.4161/hv.5.10.9518
  17. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-7. https://doi.org/10.1001/jama.2009.1201
  18. 2006 Report of national sero-epidemiologic surveillance for measles, mumps and hepatitis B. Seoul: Korea Centers for Disease Control and Prevention; 2007.
  19. Vaccine effectiveness of mumps in Korea. Seoul: Korea Centers for Disease Control and Prevention, Ulji University College of Medicine; 2007.

Cited by

  1. 일 지역 어머니의 HPV 관련 지식도 vol.11, pp.3, 2010, https://doi.org/10.5388/jkon.2011.11.3.193
  2. Rapid Increase in the National Treatment Costs for Hepatitis A Infections in Korea vol.226, pp.1, 2010, https://doi.org/10.1620/tjem.226.85
  3. 여중생 딸을 둔 어머니의 인유두종 바이러스 백신 접종 의도 및 관련 요인 vol.14, pp.8, 2014, https://doi.org/10.5392/jkca.2014.14.08.307
  4. Screening and Vaccination Against Measles and Varicella Among Health Care Workers: A Cost-effectiveness Analysis vol.33, pp.5, 2010, https://doi.org/10.1177/10105395211026468